Search

BI Access to Healthcare Strategy_Availability

Boehringer Ingelheim aspires to be a leader in ensuring improved access by delivering More Health to humans, animals and communities around the world. Read more about our holistic approach, based on partnerships and local empowerment.

World Stroke Organization Honors Eight Stroke Centers powered by Angels Award for their Efforts in developing stroke management in Egypt

World Stroke Organization Honors Eight Stroke Centers powered by Angels Award

Our Innovation Strategy

Our discovery research strategy is designed to sustain our track record of innovation and look for new and breakthrough medicines.

COVID-19 Q&A for people with chronic respiratory conditions

World Water Day: Good Health Hinges on Good Water

Clean, safe and accessible water is the most basic prerequisite for life and health

Introducing Karl and Klara Kidney

Kidney disease and type 2 diabetes are closely linked, and share many of the same risk factors and pathological pathways

NeO - smart and sustainable vaccines

The reduction in the environmental impact of the new NeO vaccine packaging illustrates Boehringer Ingelheim’s drive for environmental responsibility.

COVID-19 Global Access Commitment with Gates Foundation

Boehringer Ingelheim commits to provide global access to COVID-19 therapeutics by signing a communiqué with the Bill & Melinda Gates Foundation.

MEDEX and CRM summit discuss latest advances in CRM care

More than 300 regional experts gather in Cairo for Boehringer Ingelheim’s Forums to discuss latest advances in cardio-renal-metabolic care

Open Innovation at Boehringer Ingelheim

Learn more about how we’re working across the innovation community to advance research and accelerate the development of new medicines

COVID-19 Boehringer Ingelheim Clinical Trials

Teaching kids about pet-care

Teaching kids about pet care

More Health Overview

Working at the intersection of human and animal health, we have unique opportunities to positively impact vulnerable populations.

Facts about the INPULSIS™ trials

“Rapid progress towards clinical candidates”

Boehringer Ingelheim forms a joint venture to create the next generation of antimicrobials.

Stroke Prevention in AF

The beginning of the end for KRAS cancers

Learn how Darryl McConnell & his team are tackling the “the beating heart of cancer”

Meet Nala, a young service dog in training by Fundappas

Nala is a young service dog in training, an exciting addition to Boehringer Ingelheim’s team in Uruguay!

Empowering and Upskilling Patient Organizations in the IMETA Region

Boehringer Ingelheim held the first PULSE training programme in Dubai, bringing together over twenty representatives of patient organizations from across India, the Middle East, Turkey, and Africa.

Boehringer Ingelheim sees positive business momentum in 2020 despite impact of COVID-19

Boehringer Ingelheim inaugurates new milestone on its long-term commitment to the Kingdom

Pulmonary Fibrosis Awareness Month 2020

Hear what Peter Fang said about pulmonary fibrosis awareness month, our commitment to advancing care and our engaging new campaign, ‘the most important postcard you will ever write’

COVID-19 and Type 2 diabetes Regional experts shed light latest scientific updates and

COVID-19 and Type 2 diabetes: Regional experts shed light on the latest scientific updates and clinical practices in disease management for patient education

Landmark EMPA-KIDNEY trial showed significant benefit of empagliflozin in reducing kidney disease progression or cardiovascular death by 28% vs. placebo in people with chronic kidney disease

EMPA-KIDNEY Phase III clinical trial met its primary endpoint by demonstrating a significant kidney and cardiovascular benefit for adults living with chronic kidney disease

Fighting against rabies in Nepal

Read about a pilot project of a critical importance which aims to raise awareness and knowledge of rabies in Nepal.

About Us

Human Health

Animal Health

Science & Innovation

Partnering